These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 1782333

  • 1. Potential thrombogenicity of heat-treated prothrombin complex concentrates in Haemophilia B.
    Hampton KK, Makris M, Kitchen S, Preston FE.
    Blood Coagul Fibrinolysis; 1991 Oct; 2(5):637-41. PubMed ID: 1782333
    [Abstract] [Full Text] [Related]

  • 2. Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
    Mannucci PM, Bauer KA, Gringeri A, Barzegar S, Bottasso B, Simoni L, Rosenberg RD.
    Blood; 1990 Dec 15; 76(12):2540-5. PubMed ID: 2265248
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.
    MacGregor IR, Ferguson JM, McLaughlin LF, Burnouf T, Prowse CV.
    Thromb Haemost; 1991 Nov 01; 66(5):609-13. PubMed ID: 1803625
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo models of thrombogenic potential: usefulness and limitations.
    MacGregor I, McLaughlin L, Drummond O, Prowse C, Ferguson J.
    Acta Haematol; 1995 Nov 01; 94 Suppl 1():18-23; discussion 24. PubMed ID: 7571990
    [Abstract] [Full Text] [Related]

  • 7. Increased fibrinopeptide A after prothrombin complex concentrates.
    Viganó S, Cattaneo M, Gervasoni W, Mannucci PM.
    Thromb Haemost; 1980 Oct 31; 44(2):72-5. PubMed ID: 6779400
    [Abstract] [Full Text] [Related]

  • 8. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
    Tomokiyo K, Nakatomi Y, Araki T, Teshima K, Nakano H, Nakagaki T, Miyamoto S, Funatsu A, Iwanaga S.
    Vox Sang; 2003 Nov 31; 85(4):290-9. PubMed ID: 14633255
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates.
    Dusel CH, Grundmann C, Eich S, Seitz R, König H.
    Blood Coagul Fibrinolysis; 2004 Jul 31; 15(5):405-11. PubMed ID: 15205589
    [Abstract] [Full Text] [Related]

  • 13. Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients.
    Staudinger T, Frass M, Rintelen C, Quehenberger P, Wagner O, Stoiser B, Locker GJ, Laczika K, Knapp S, Watzke H.
    Intensive Care Med; 1999 Oct 31; 25(10):1105-10. PubMed ID: 10551966
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor IX concentrate compared with a prothrombin complex concentrate.
    Ruiz-Sáez A, Hong A, Arguello A, Echenagucia M, Boadas A, Fabbrizzi F, Minichilli F, Bosch NB.
    Haemophilia; 2005 Nov 31; 11(6):583-8. PubMed ID: 16236107
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics, thrombogenicity and safety of a double-treated prothrombin complex concentrate.
    Morfini M, Longo G, Berntorp E, Cinotti S, Filimberti E, Messori A, Nilsson IM, Rossi Ferrini P.
    Thromb Res; 1993 Aug 01; 71(3):175-84. PubMed ID: 8211885
    [Abstract] [Full Text] [Related]

  • 20. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ, Patiwael S, Tripathi S, Meijers JC.
    Thromb Res; 2016 Mar 01; 139():102-10. PubMed ID: 26916304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.